Thrombotic Events
Showing 1 - 25 of >10,000
Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)
Not yet recruiting
- Thrombotic Disorder
- N-acetyl-cysteine
- +3 more
- (no location specified)
Jun 8, 2023
High Incidence of Thrombotic Events in Patients With MN and DKD
Active, not recruiting
- Glomerulonephritis, Membranous
- +3 more
- Grouping based on previous laboratory results, no intervention.
-
Jinan, Shandong, ChinaQianfoshan Hospital
Dec 7, 2022
Knee Prosthesis Trial in Marseille (Thrombotic risk assessment)
Not yet recruiting
- Knee Prosthesis
- Thrombotic risk assessment
-
Marseille, Bouches Du Rhône, FranceAssistance Publique Hopitaux de Marseille
Aug 12, 2022
Unleash the Mystery of COVID-19 Related Unusual Thrombosis
Recruiting
- COVID-19
- Thrombophilia screening
-
Sohag, Egypt, Faculty of Medicine, Sohag University
May 3, 2022
Antithrombin III Deficiency in Adult Patients With ECMO
Completed
- Antithrombin III Deficiency
- Extracorporeal Membrane Oxygenation Complication
- Antithrombin III
-
Istanbul, TurkeyIstanbul Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Tra
May 22, 2022
Antithrombin III Deficiency Trial (Plasma-derived AT-III concentrate)
Active, not recruiting
- Antithrombin III Deficiency
- Plasma-derived AT-III concentrate
- (no location specified)
May 5, 2022
Genomics and COVID-19 Vaccine Adverse Events
Recruiting
- Vaccine Adverse Reaction
- COVID-19 vaccines
-
Vancouver, British Columbia, CanadaBritish Columbia Children's Hospital Research Institute
Jun 24, 2022
Coronary Artery Disease Trial in Seoul (Aspirin, Clopidogrel)
Recruiting
- Coronary Artery Disease
-
Seoul, Korea, Republic ofSamsung Medical Center
Feb 8, 2022
Biomarkers of Acute Stroke in Clinic
Recruiting
- Ischemic Stroke
- +16 more
- ISCDX blood test
-
Columbus, OhioOhio Health Riveside Methodist Hospital
Aug 23, 2021
Chronic Subdural Hematoma Trial in Basel (Acetylsalicylic acid, Placebo Oral Tablet)
Recruiting
- Chronic Subdural Hematoma
- Acetylsalicylic acid
- Placebo Oral Tablet
-
Basel, SwitzerlandDepartment of Neurosurgery
Jun 25, 2020
Cardiac Disease Trial in Worldwide (Edoxaban, Standard of Care (SOC))
Symptomatic Aortic Stenosis, Eligible for Transcatheter Aortic Valve Replacement Trial in Worldwide (Apixaban, Standard of care)
Completed
- Symptomatic Aortic Stenosis
- Eligible for Transcatheter Aortic Valve Replacement
- Apixaban
- Standard of care
-
Paris, France
- +3 more
Feb 24, 2021
Thrombotic and Bleeding Events Trial in Canada, United Kingdom, United States (On-X Aortic Heart Valve replacement)
Active, not recruiting
- Thrombotic and Bleeding Events
- On-X Aortic Heart Valve replacement
-
Tucson, Arizona
- +23 more
Apr 4, 2022
End Stage Renal Disease Requiring Hemodialysis Trial in Worldwide (BAY2976217, Placebo)
Completed
- End Stage Renal Disease Requiring Hemodialysis
- BAY2976217
- Placebo
-
Clovis, California
- +68 more
Jan 20, 2023
Ibd CAncer and seRious Infections in France (I-CARE 2)
Not yet recruiting
- IBD
- +2 more
- Non-interventional
-
Amiens, France
- +1 more
Oct 13, 2023
Thrombin Generation Parameters in Patients on ECMO Support:Pilot
Recruiting
- Extracorporeal Circulation; Complications
- Extracorporeal Membrane Oxygenation Complication
- DIC markers and Thrombin Generation Parameters
-
Hong Kong, Hong KongQueen Mary Hospital
Oct 18, 2023
GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating
Active, not recruiting
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
-
Durham, North CarolinaRTI Health Solutions
Jun 14, 2022
Venous Thromboembolism, covid19, Thrombosis Trial in Ryazan' (standard of care anticoagulation in absence of thrombotic
Recruiting
- Venous Thromboembolism
- +2 more
- standard of care anticoagulation in absence of thrombotic complications
- +2 more
-
Ryazan', Russian FederationRyazan State Medical University
Feb 2, 2022
Behcet's Syndrome, Vascular Type Trial in Assiut (Hydroxychloroquine)
Unknown status
- Behcet's Syndrome, Vascular Type
-
Assiut, EgyptAssiut University Hospital
Jul 23, 2019
Antithrombin III Deficiency Trial in Brussel (observation)
Not yet recruiting
- Antithrombin III Deficiency
- observation
-
Brussel, BelgiumUZ Brussel
May 26, 2023
National Marrow Donor Program Long-Term Donor Follow-Up
Completed
- Hematologic Neoplasms
-
Duarte, California
- +28 more
Oct 19, 2020
Epigenetic Age on Clinic-biological Presentation and Prognosis
Not yet recruiting
- Myeloproliferative Neoplasm
- Assessment of the epigenetic age
-
Bordeaux, FranceCHU de Bordeaux, service Hématologie Biologique
Aug 28, 2023
Coronary Artery Ectasia Trial (Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg)
Not yet recruiting
- Coronary Artery Ectasia
- Rivaroxaban 2.5 Mg Oral Tablet twice daily
- +2 more
- (no location specified)
Jan 30, 2023